Dallas, Texas, Oct. 28, 2022 (GLOBE NEWSWIRE) -- It is anticipated that an increase in the prevalence of genetic disorders and infectious diseases, as well as an increase in the number of diagnostic facilities and hospitals, will drive the global real-time PCR (QPCR) market. Over the past few years, there has been significant growth in the use of genomic analytic methods for the detection of serious genetic disorders and infectious diseases (including HIV, TB, malaria, and hepatitis). Among the numerous technological developments in the medical field, nucleic acid detection-based methods have emerged as quick and accurate tools for viral identification. The qualitative PCR technique, which is regarded as the "gold standard" for virus identification, is distinguished by its high sensitivity, speedy detection, and specificity. Many nations are carrying out research funding to support COVID-19 treatment.
The emergence of new market participants engaged in new product launches, acquisitions, and strategic partnerships is driving the steady growth of the global real-time PCR (qPCR) market. The real-time PCR (qPCR) market's value chain analysis is divided into four main segments, starting with research and development and designing, moving on to product production, distribution, and sales, and concluding with post-sales services.
Request for a sample report here: https://www.adroitmarketresearch.com/contacts/request-sample/3606
Real Time PCR (QPCR) Market Players Overview
- Thermofischer Scientific Inc.
- Bio-Rad Laboratories Inc.
- Agilent Technologies, Inc.
- BIOTECON Diagnostics
- Sigma-Aldrich Co. LLC.
- Takara Bio Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- QIAGEN N.V.
Techniques used in molecular biology labs that are based on polymerase chain reactions include real-time polymerase chain reactions (PCR). However, in the fields of clinical and veterinary diagnostics as well as food safety, real-time PCR is a well-known method for the detection, quantification, and type of many microbial agents. Even though the PCR principle is extremely simple, qPCR has certain unique issues that developers and users of this technology need to be aware of. The size of the global real-time PCR (QPCR) market was estimated at USD 5,192.97 million and is expected to reach USD 10,880.30 million by 2030, expanding at a CAGR of 8.73% during the projection period.
Real Time PCR (QPCR) Market Type Overview
- Real-Time PCR (qPCR) Systems
- Reagents and Assays
- Real-Time PCR (qPCR) Consumables
- PCR Primers, Assays, and Arrays
- PCR Plates, Seals & Tubes
Real Time PCR (QPCR) Market Application Overview
- Clinical
- Research
- Forensics
- Others
Real Time PCR (QPCR) Market Downstream Fields Overview
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Contract Research Organizations
- Animal Health
- Food & Agriculture Industries
Ask our Expert if You Have a Query at: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/3606
This market is predicted to grow at the quickest rate due to the technology's rising applications in research into cancer and tumors, prenatal diagnosis, and gene expression studies. Quantitative PCR dominated the digital PCR markets. Because medical biotechnology has such a wide range of applications and potential uses, this rise is anticipated to continue during the predicted period.
North America continues to have a dominant market share of over 57.03% in the real-time PCR (qPCR) industry. The dominance of North America in this market sector is attributed to factors such as increased usage of cutting-edge genetic analysis tools and the accessibility of R&D grants. In the Asia Pacific, it is projected that a high prevalence of chronic & infectious diseases, together with rising patient awareness regarding early diagnosis of these diseases, will increase demand for PCR products, ultimately fueling the market's expansion over the next few years.
The Azure Cielo Real-time PCR apparatus was introduced in June 2020 by Azure Biosystems (US). High performance, a small footprint, and an easy workflow are all features of this 96-well qPCR machine. The Azure Biosystem's sensitivity and repeatability have been devoted to the genomics workflow.
Direct Purchase Report @ https://www.adroitmarketresearch.com/researchreport/purchase/3606
About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1-9726644514, +91-9665341414
Connect with us: Facebook | Twitter | LinkedIn
